Home Newsfeeds USA CPI (YoY) for Jun 9.100% vs 8.800% Est; Prior 8.600%

USA CPI (YoY) for Jun 9.100% vs 8.800% Est; Prior 8.600%

USA CPI (YoY) for Jun 9.100% vs 8.800% consensus estimate. The prior reading was 8.600%.

byBill Haddad

July 13, 2022

1 minute read

USA CPI (YoY) for Jun 9.100% vs 8.800% consensus estimate. The prior reading was 8.600%.

Here’s How Much $1000 Invested In Tesla 10 Years Ago Would Be Worth Today

By Benzinga Insights

August 29, 10:06 AM

Tesla (NASDAQ:TSLA) has outperformed the market over the past 10 years by 54.27% on an annualized basis producing an average annual return of 65.35%. Currently, Tesla has a market capitalization of $897.49 billion.

TSLA

Why Take-Two Stock Is Taking Off After Hours

By Adam Eckert

May 17, 4:29 PM

Take-Two Interactive Software Inc (NASDAQ: TTWO) shares are trading higher after the close Wednesday on the heels of the company's fourth-quarter results.

TTWO

Imperial Brands Extends $123M Convertible Debenture And Auxly Implements Board And Management Changes

By Vuk Zdinjak

July 27, 11:48 AM

Auxly Cannabis Group Inc. (OTCQB: CBWTF) (TSX:XLY) entered into an agreement with its strategic partner, Imperial Brands PLC to amend certain provisions of its previously issued $123 million debenture dated September 25, 2019 as amended on July 6, 2021.

CBWTF

Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At ‘Psychedelic-Assisted Therapies’

By Lara Goldstein

July 18, 3:54 PM

COMPASS Pathways (NASDAQ: CMPS) shared results from an open-label Phase 2 trial assessing its synthetic psilocybin COMP360 alongside SSRIs for Treatment-Resistant Depression (TRD.)

CMPS

USA CPI (YoY) for Jun 9.100% vs 8.800% Est; Prior 8.600%

Related Posts

Here’s How Much $1000 Invested In Tesla 10 Years Ago Would Be Worth Today

Why Take-Two Stock Is Taking Off After Hours

Imperial Brands Extends $123M Convertible Debenture And Auxly Implements Board And Management Changes

Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At ‘Psychedelic-Assisted Therapies’